These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10614698)

  • 1. Fetal growth and adverse birth outcomes in women receiving prescriptions for acetaminophen during pregnancy. EuroMap Study Group.
    Thulstrup AM; Sørensen HT; Nielsen GL; Andersen L; Barrett D; Vilstrup H; Olsen J
    Am J Perinatol; 1999; 16(7):321-6. PubMed ID: 10614698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Congenital malformations and fetal growth of children with intrauterine exposure to anticonvulsants].
    Fonager KM; Larsen H; Pedersen L; Sørensen HT
    Ugeskr Laeger; 2001 Nov; 163(45):6279-83. PubMed ID: 11723688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study.
    Ratanajamit C; Skriver MV; Nørgaard M; Jepsen P; Schønheyder HC; Sørensen HT
    J Antimicrob Chemother; 2003 Nov; 52(5):837-41. PubMed ID: 14519675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
    Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
    J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones.
    Wogelius P; Nørgaard M; Gislum M; Pedersen L; Schønheyder HC; Sørensen HT
    Int J Antimicrob Agents; 2005 Oct; 26(4):323-6. PubMed ID: 16144758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetaminophen use during pregnancy: effects on risk for congenital abnormalities.
    Rebordosa C; Kogevinas M; Horváth-Puhó E; Nørgård B; Morales M; Czeizel AE; Vilstrup H; Sørensen HT; Olsen J
    Am J Obstet Gynecol; 2008 Feb; 198(2):178.e1-7. PubMed ID: 18226618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes.
    Rebordosa C; Kogevinas M; Bech BH; Sørensen HT; Olsen J
    Int J Epidemiol; 2009 Jun; 38(3):706-14. PubMed ID: 19332503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trauma during pregnancy: an analysis of maternal and fetal outcomes in a large population.
    El-Kady D; Gilbert WM; Anderson J; Danielsen B; Towner D; Smith LH
    Am J Obstet Gynecol; 2004 Jun; 190(6):1661-8. PubMed ID: 15284764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivmecillinam and adverse birth and neonatal outcomes: a population-based cohort study.
    Vinther Skriver M; Nørgaard M; Pedersen L; Carl Schønheyder H; Sørensen HT
    Scand J Infect Dis; 2004; 36(10):733-7. PubMed ID: 15513399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescriptions filled during pregnancy for drugs with the potential of fetal harm.
    Kulaga S; Zargarzadeh AH; Bérard A
    BJOG; 2009 Dec; 116(13):1788-95. PubMed ID: 19832828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking habits, nicotine use, and congenital malformations.
    Morales-Suárez-Varela MM; Bille C; Christensen K; Olsen J
    Obstet Gynecol; 2006 Jan; 107(1):51-7. PubMed ID: 16394039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
    Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
    Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice and chance: determinants of short interpregnancy intervals in Denmark.
    Kaharuza FM; Sabroe S; Basso O
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):532-8. PubMed ID: 11380289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A follow-up study of birth outcome in users of pivampicillin during pregnancy.
    Larsen H; Nielsen GL; Sørensen HT; Møller M; Olsen J; Schønheyder HC
    Acta Obstet Gynecol Scand; 2000 May; 79(5):379-83. PubMed ID: 10830765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
    Vega J; Sáez G; Smith M; Agurto M; Morris NM
    Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
    Rahme E; Pettitt D; LeLorier J
    Arthritis Rheum; 2002 Nov; 46(11):3046-54. PubMed ID: 12428249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
    Viktil KK; Engeland A; Furu K
    Scand J Rheumatol; 2012 May; 41(3):196-201. PubMed ID: 22401133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-pregnancy weight and the risk of stillbirth and neonatal death.
    Kristensen J; Vestergaard M; Wisborg K; Kesmodel U; Secher NJ
    BJOG; 2005 Apr; 112(4):403-8. PubMed ID: 15777435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and neonatal outcomes of assaults during pregnancy.
    El Kady D; Gilbert WM; Xing G; Smith LH
    Obstet Gynecol; 2005 Feb; 105(2):357-63. PubMed ID: 15684165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High parity and fetal morbidity outcomes.
    Aliyu MH; Salihu HM; Keith LG; Ehiri JE; Islam MA; Jolly PE
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1045-51. PubMed ID: 15863543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.